Acthar and Acute kidney failure - a phase IV clinical study of FDA data

Summary:

Acute kidney failure is reported as a side effect among people who take Acthar (corticotropin), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Protonix, and have Nephrotic syndrome.

The phase IV clinical study analyzes which people have Acute kidney failure when taking Acthar. It is created by eHealthMe based on reports of 4,932 people who have side effects when taking Acthar from the FDA, and is updated regularly.

What is Acthar?

Acthar has active ingredients of corticotropin. eHealthMe is studying from 4,948 Acthar users. Check the latest studies of Acthar.

What is Acute kidney failure?

Acute kidney failure is found to be associated with 2,835 drugs and 4,492 conditions by eHealthMe. Check the latest studies of Acute kidney failure.

On Apr, 24, 2026

4,932 people reported to have side effects when taking Acthar.
Among them, 46 people (0.93%) have Acute kidney failure.

Could Acthar cause Acute kidney failure?

Among these 46 people:

How long have people been on Acthar when they have Acute kidney failure? *

What is the gender of people who have Acute kidney failure when taking Acthar? *

female: 44.44 %
male: 55.56 %

What is the age of people who have Acute kidney failure when taking Acthar? *

What are other drugs people take besides Acthar? *

What are other side effects people have besides Acute kidney failure? *

High Blood Pressure: 8 people, 17.39%
Malaise (a feeling of general discomfort or uneasiness): 7 people, 15.22%
Weight Increased: 6 people, 13.04%
Insomnia (sleeplessness): 5 people, 10.87%
Pain: 5 people, 10.87%
Chronic Kidney Disease: 5 people, 10.87%
Oedema (fluid collection in tissue): 5 people, 10.87%
Drug Ineffective: 5 people, 10.87%
Fall: 4 people, 8.70%
Pain In Extremity: 4 people, 8.70%

What are the existing conditions these people have? *

Nephrotic Syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema): 8 people, 17.39%
Focal Segmental Glomerulosclerosis (scar tissue that forms in parts of the kidney called glomeruli): 5 people, 10.87%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 10.87%
High Blood Cholesterol: 5 people, 10.87%
High Blood Pressure: 5 people, 10.87%
Lupus Nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue): 4 people, 8.70%
Pain: 4 people, 8.70%
Fluid Retention (an abnormal accumulation of fluid in the blood): 3 people, 6.52%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 3 people, 6.52%
Glomerulonephritis Membranous (nephritis with inflammation of the capillary loops in the renal glomeruli): 3 people, 6.52%

* Approximation only. Some reports may have incomplete information.

Do you take Acthar and have Acute kidney failure?

- Check whether Acute kidney failure is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Acthar:

Acthar (4,948 reports)

Browse all side effects of Acthar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Acute kidney failure:

Acute kidney failure (2,835 drugs)

Browse all the conditions that are associated with Acute kidney failure:

Acute kidney failure (4,492 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on corticotropin (the active ingredients of Acthar) and Acthar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.